ALT vs C · rev $20.0K vs P/E 16, rev $85.22B
Altimmune Inc (ALT) versus Citigroup Inc. (C) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
ALT currently screens at market cap $527.0M. C currently screens at market cap $214.73B and trailing P/E 15.5.
Not investment advice. Open the ALT and C stock pages for the full models.
Not investment advice.